Windtree Therapeutics Inc at Lytham Partners Spring Investor Conference (Virtual) Transcript
All right. Hello, everyone, and thank you all for joining us during the Lytham Partners Spring 2022 Investor Conference. My name is Robert Blum, Managing Partner of Lytham Partners. And during this presentation, we welcome Windtree Therapeutics -- ticker symbol of WINT on the NASDAQ -- and the company's Chief Executive Officer, Craig Fraser. Today, I've asked Craig to run through the slide presentation, and we will then engage in a short fireside chat-like Q&A session.
Before I do turn it over to Craig, I want to remind everyone that the company is available for one-and-one meetings later this week. (Conference Instructions)
So with that said, let me turn the presentation over to Craig Fraser, Chief Executive Officer, Windtree Therapeutics. Craig, please proceed.
Thank you, Robert. I hope everybody is doing well and has a very productive conference. I'm going to share my slides very quickly here. And I've been looking
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |